Johnson & Johnson (NYSE:JNJ) is among the most profitable mega cap stocks to buy. On February 6, Johnson & Johnson (NYSE:JNJ) disclosed 12-month pilot-phase data from the OMNY-AF study, which examined the investigational OMNYPULSE Platform for the treatment of symptomatic paroxysmal atrial fibrillation (AFib). Announced during the 31st Annual AF Symposium in Boston, the results reveal that investigators achieved 100% acute procedural success with zero adverse events linked to the procedure. As stated by D ...

Core Insights - Johnson & Johnson (NYSE: JNJ) is recognized as a strong investment opportunity in the medical research sector, particularly highlighted by hedge funds [1] - The company reported promising results from the OMNY-AF study, achieving 100% acute procedural success and 90% primary effectiveness at 12 months for the OMNYPULSE Platform [1] - RBC Capital and BofA have both raised their price targets for JNJ shares, indicating positive market sentiment and expectations for growth [2][3] Group 1: Study Results - The OMNY-AF study showed that 100% of procedures were successful with no adverse events reported [1] - 56.7% of cases were performed without fluoroscopy, showcasing advancements in procedural techniques [1] - 90% of patients achieved primary effectiveness at the 12-month mark, indicating strong long-term outcomes [1] Group 2: Market Sentiment and Price Targets - RBC Capital increased its price target for JNJ from $240 to $255 while maintaining an Outperform rating, reflecting confidence in the company's financial position despite ongoing litigation [2] - BofA raised its price target from $221 to $227, suggesting a higher blended P/E multiple and expectations for organic growth in both MedTech and pharmaceuticals [3] Group 3: Company Overview - Johnson & Johnson operates in the healthcare sector through two main segments: Innovative Medicine and MedTech [4] - The Innovative Medicine segment addresses various therapeutic areas, including oncology and infectious diseases, while the MedTech segment focuses on a wide range of medical devices [4]